Sanjay Shukla
Chief Executive Officer en ATYR PHARMA, INC. .
Fortuna: 227 269 $ al 31/03/2024
Perfil
Dr. Sanjay S.
Shukla, MD, is a President, Chief Executive Officer & Director at aTyr Pharma, Inc. He is on the Board of Directors at aTyr Pharma, Inc. Dr. Shukla was previously employed as a Vice President & Head-Integrated Medical Services by Novartis AG and a Chief Executive Officer by Rxmd, Inc. He received his undergraduate degree from the University of Maryland, a graduate degree from the University of Maryland and a doctorate degree from Howard University College of Medicine.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
ATYR PHARMA, INC.
0.17% | 01/03/2024 | 116 548 ( 0.17% ) | 227 269 $ | 31/03/2024 |
Cargos activos de Sanjay Shukla
Empresas | Cargo | Inicio |
---|---|---|
ATYR PHARMA, INC. | Chief Executive Officer | 01/11/2017 |
Antiguos cargos conocidos de Sanjay Shukla.
Empresas | Cargo | Fin |
---|---|---|
NOVARTIS AG | Corporate Officer/Principal | 01/04/2015 |
Rxmd, Inc. | Chief Executive Officer | 01/09/2012 |
Formación de Sanjay Shukla.
University of Maryland | Graduate Degree |
Howard University College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ATYR PHARMA, INC. | Health Technology |
NOVARTIS AG | Health Technology |
Empresas privadas | 1 |
---|---|
Rxmd, Inc. |
- Bolsa de valores
- Insiders
- Sanjay Shukla